| July 31, 2010 | Home | EECP Forum | Contact |
 |
|
What's New
VasoHealthcare Holds Launch Summit 2010 In Greensboro, NC Vasomedical Releases iPhone Application for EECP® Therapy Vasomedical Announces Reorganization of Its Board of Directors Vasomedical Announces FDA 510(k) Clearance on the First Combined ECG Holter and Ambulatory Blood Pressure Monitoring System |
Overview of EECP® Therapy
EECP therapy is offered exclusively by Vasomedical, Inc., the pioneer and world leader in the design and development of external counterpulsation systems. Vasomedical EECP therapy systems are the ONLY external counterpulsation devices clinically proven to be safe and effective in treating patients with angina and heart failure. Safety, effectiveness and long-term sustained benefit have been scientifically validated through randomized, controlled clinical trials and registry data published in leading peer-reviewed medical journals. "The long-term care of patients with chronic coronary artery disease requires the cardiologist to use aggressive preventive methods and more cost-effective treatments to improve clinical and financial outcomes. EECP treatment is a safe, cost-effective, non-invasive method of restoring myocardial perfusion and reducing symptoms of angina. EECP treatment is the perfect disease management tool for chronic coronary artery disease.” John E. Strobeck, M.D., Ph.D. EECP therapy is provided at some of the world’s leading institutions including the Mayo Clinic, Cleveland Clinic, University of California at San Francisco and San Diego, Duke University Medical Center, University of Pittsburgh Medical Center, and many more. Build your practice and broaden your spectrum of services with EECP therapy. Clinical training and support, patient recruitment program, reimbursement support and public relations are included in the comprehensive package physician practices and health care centers receive from Vasomedical. |